Llwytho...
JAK2 Inhibitors: What’s the true therapeutic potential?
Physicians treating patients with the classic Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs) (polycythemia vera [PV], essential thrombocythemia [ET] and primary myelofibrosis [PMF]) traditionally had few therapeutic drugs available. Spurred by the discovery of activating mutat...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Blood Rev |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406394/ https://ncbi.nlm.nih.gov/pubmed/21095048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2010.10.004 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|